[1] 李志明,王育斌,施子诺.血清脂联素在非酒精性脂肪性肝病发病中的意义[J]. 现代医药卫生,2007,23(21):3162-3163. [2] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J]. 实用肝脏病杂志,2007,10(1):1-3. [3] 孙伟,姜政,王丕龙.脂联素及其在非酒精性脂肪性肝病中的作用研究进展[J]. 中华肝脏病杂志,2006,12(4):952-953. [4] 杨玉锋,南月敏.脂联素与非酒精性脂肪性肝病的研究进展[J]. 临床肝胆病杂志,2009,25(2):155-157. [5] XU A,WANG Y,KESHAW H,et al.The fat-derived hormone adipoonectin alleviates alcoholic and nonalcoholic tiatty liver diseases in mice[J]. Clin Invest,2003,112:95-100. [6] YOU M,CONSIDINE R V,LEONE T C,et al.Role of adiponectin in the protective acion of dietary saturated fat against alcoholic fatty liver in micw[J]. Hepatology,2005,42:568-577. [7] YAMAUCHI T,KAMON J,ITO Y,et al.Cloming of adiponectin receptors that mediate antidiabetic metabolic effects[J]. Nature,2003,423:762-769. [8] KAZUMI T,KAWAGUCHI A,HIRANO T,et al.Serum adiponectin is associated with high-density liopoprotein cholesterol,triglycerides,and low-density lipoprotein particle size in Young healthy men[J]. Metabolism,2004,53:589-593. [9] 赵庆华,李新,路玉娇,等. 非酒精性脂肪性肝病患者脂联素水平检测及意义[J]. 中国医师进修杂志,2006,12: 33-35. [10] 周婷婷,秦波. 脂肪细胞因子与非酒精性脂肪肝和胰岛素抵抗关系的研究进展[J]. 世界华人消化杂志,2009,17(29):3014-3018. [11] MASAKI T,CHIBA S,TATSUKAKA H,et al.Adiponectin protects LPS-induced live injury through modulation of TNF alpha in KK-AY obese mie [J]. Hepatology,2004,40:177-184. |